After additional mutation filtering to remove variants labeled as “benign” or “likely benign” in the ClinVar database, potential pathogenic HR mutations remain prevalent compared with BRCA2/PTEN/BRCA1 mutations (Supplementary Figure S1C), suggesting that HR mutation might function as a risk factor for BC. This evidence concerns the gene PTEN and breast cancer.